Change is needed
Updated: Dec 9, 2019
I think over the next five years, it has to be an earlier engagement. I think patient be engaged early in the process. And that might be before it even gets in to man. So that could be involving or seeking the support or guidance or information from patients at Benchstage. I think patient-centricity probably needs to become a little bit more philanthropic. I think there needs to be a focus on, once you are launched, maintaining the engagement but talking about wider subjects around a patient's lives. Pharmacuetical companies are very focused, and quite correctly, on safety and efficacy, but there are other aspects to patients' lives that illnesses impact. And understanding and communicating that I think would help the engagement environment.